Location History:
- Princeton, NJ (US) (2014 - 2016)
- Cambridge, MA (US) (2020)
- Newton, MA (US) (2014 - 2024)
Company Filing History:
27 out of 8,369 
5 out of 34 
2 out of 1,079 
Years Active: 2014-2025
Title: Ron Weiss: Pioneering Innovator in Cancer Immunotherapy and Logic Gates
Introduction:
Meet Ron Weiss, a renowned inventor and researcher based in Newton, MA, USA. With an impressive portfolio of 25 patented inventions, Weiss has made significant contributions in the fields of cancer immunotherapy and genetic logic gates. This article delves into his latest patents, career highlights, collaborations, and his invaluable contributions to the fields of science and technology.
Latest Patents:
Weiss's recent patents reflect his groundbreaking work in synthetic oncolytic viruses and miRNA-based logic gates. The patent titled "Synthetic oncolytic LNP-replicon RNA and uses for cancer immunotherapy" explores the development of synthetic oncolytic viruses that leverage lipid nanoparticles for delivering replicon RNA encoding immunomodulatory molecules. This innovation holds great potential for cancer immunotherapy by harnessing the body's natural defense mechanisms to eradicate cancer cells.
Another noteworthy patent is the "MicroRNA-based logic gates and uses thereof," which introduces an RNA carrier embedded with a nuclear export signal and target sites for specific microRNAs. These engineered carriers act as logic gates in genetic circuits, enabling programmable control of gene expression. This technology opens doors for advanced genetic engineering and precision medicine applications.
Career Highlights:
Weiss's career trajectory has been shaped by significant collaborations and affiliations with prestigious institutions. Notably, he has been associated with the Massachusetts Institute of Technology (MIT) where he has contributed to groundbreaking research in synthetic biology. His work at MIT has garnered worldwide recognition and has served as a catalyst for advancements in genetic circuits and system biology.
Additionally, Weiss has made significant contributions to Moderna Therapeutics, Inc., a pioneering biotechnology company at the forefront of mRNA-based therapeutics. His innovative research continues to propel the development of novel treatments and vaccines utilizing mRNA technology.
Collaborations:
Ron Weiss has been privileged to work with esteemed colleagues throughout his career, fostering a culture of collaboration and intellectual growth. Two notable collaborators are Tirtha Chakraborty and Antonin De Fougerolles. Chakraborty, a renowned scientist in the field of synthetic biology, has collaborated closely with Weiss, resulting in several impactful research projects. De Fougerolles, a prominent figure in the biotechnology industry, has provided valuable industry-focused insights and contributed to advancing Weiss's research into practical applications.
Conclusion:
Ron Weiss's inventive genius and unwavering dedication to scientific progress have paved the way for powerful innovations in cancer immunotherapy and genetic logic gates. With his extensive patent portfolio and remarkable collaborations with leading institutions and researchers, Weiss has established himself as a trailblazer in the field of synthetic biology. Through his discoveries, he continues to revitalize the landscape of medicine and genetic engineering, offering hope for improved treatments and personalized therapies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.